Atogepant Side Effects: What to Expect and When to Call Your Doctor

Atogepant (Qulipta) is generally well-tolerated compared to older migraine preventives. Most patients who experience side effects report mild ones that improve within the first few weeks. That said, knowing what to watch for — and when to call your doctor — helps you stay safe and get the most out of treatment.

This guide covers the most common and the most serious side effects of atogepant, with plain-English explanations and clear guidance on when to seek medical attention.

Does Atogepant Have a Boxed Warning?

No. Atogepant does not have an FDA boxed warning (the most serious type of safety warning). This distinguishes it from some older migraine preventives — for example, topiramate has boxed warnings about fetal harm and metabolic acidosis.

Common Side Effects of Atogepant

The most common side effects in clinical trials — occurring in at least 4% of patients and more frequently than with placebo — were:

• Nausea — the most frequently reported side effect. Typically mild and often improves within the first 1–2 weeks. Taking atogepant with food may help.
• Constipation — another commonly reported GI effect. Staying well-hydrated and increasing dietary fiber can help manage this.
• Fatigue or somnolence (sleepiness) — some patients feel tired, especially in the first few weeks. Try taking atogepant in the evening if fatigue is bothersome.
• Decreased appetite — a reduction in hunger has been reported in some patients.
• Weight loss — related to decreased appetite. Usually modest. Monitor if clinically significant.

In the large pivotal ADVANCE trial (12 weeks, 1,958 participants), atogepant was generally well-tolerated with most side effects being mild to moderate in severity.

Serious Side Effects: What to Watch For

While uncommon, the following serious side effects have been reported with atogepant and require prompt medical attention:

• Hypersensitivity reactions (allergic reactions): Cases have included anaphylaxis, difficulty breathing, rash, itching, hives, and facial swelling. These can occur days after administration — not just immediately. Stop atogepant and seek emergency care immediately if you experience swelling of the face, lips, or throat; difficulty breathing; or severe rash.
• Hypertension (high blood pressure): New-onset or worsening of pre-existing high blood pressure has been reported with CGRP antagonists including atogepant. It most commonly appears within the first 7 days of treatment. Some cases required new blood pressure medication or hospitalization. Monitor your blood pressure, especially in the first week.
• Raynaud's phenomenon: Cases of Raynaud's phenomenon (reduced blood flow to fingers/toes, often in response to cold) have been reported. Symptoms typically start a median of 1.5 days after starting the medication. Tell your doctor if you notice color changes in your fingers or toes.

Contraindications: Who Should NOT Take Atogepant

Atogepant is contraindicated (should not be used) in:

• Patients with a history of hypersensitivity to atogepant or any of its inactive ingredients
• Patients with severe hepatic impairment
• Chronic migraine patients with severe renal impairment (CLcr <30 mL/min) or ESRD

Special Populations: Pregnancy and Breastfeeding

Atogepant is only FDA-approved for adults. It is not known whether atogepant is safe during pregnancy — animal studies showed developmental effects at doses higher than those used clinically. If you are pregnant or planning pregnancy, discuss the risks and benefits with your doctor. It is also unknown whether atogepant passes into breast milk.

When Should You Call Your Doctor?

Call your doctor if you experience:

• Nausea or constipation that doesn't improve after 2–3 weeks
• Significant weight loss or appetite changes
• Any new rash, itching, or skin reactions
• High blood pressure or new headaches that feel different from your migraines
• Color changes in your fingers or toes (possible Raynaud's)

Seek emergency care immediately for: difficulty breathing, swelling of the face/lips/tongue/throat, or severe hives — signs of a serious allergic reaction.

How Does Atogepant Compare to Older Preventives for Side Effects?

Atogepant generally has a favorable side effect profile compared to older preventives. Topiramate, for example, is associated with cognitive slowing ("topamax fog"), vision changes, kidney stones, and a boxed warning about fetal harm. Propranolol can cause fatigue, bradycardia, and is contraindicated in asthma. Amitriptyline causes significant sedation and anticholinergic effects. In comparison, atogepant's profile of nausea, constipation, and mild fatigue is generally more manageable. See our full comparison guide to alternatives to atogepant.